XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Investments:    
Fixed maturities available-for-sale, at fair value (amortized cost of $69,340 and $68,636) (allowance for credit losses of $19 and $22) $ 62,674 $ 73,076
Mortgage loans on real estate (net of allowance for credit losses of $64 and $62) 14,463 14,016
Policy loans 3,544 3,540
Other equity investments [1] 2,968 2,759
Trading securities, at fair value 345 379
Other invested assets 1,443 2,910
Total investments 85,437 96,680
Cash and cash equivalents 2,316 1,815
Deferred policy acquisition costs 5,490 4,267
Amounts due from reinsurers (allowance for credit losses of $6 and $5) (includes amounts accounted for at fair value of $4,681 and $5,813) [2] 12,399 13,300
Loans to affiliates 1,900 1,900
GMIB reinsurance contract asset, at fair value 1,612 2,068
Current and deferred income taxes 2,302 842
Other assets 4,782 3,023
Separate Accounts assets 113,780 143,912
Total Assets 230,018 267,807
LIABILITIES    
Policyholders’ account balances 74,908 75,467
Future policy benefits and other policyholders' liabilities 34,193 36,851
Broker-dealer related payables 174 630
Amounts due to reinsurers 125 135
Other liabilities 3,316 2,078
Separate Accounts liabilities 113,780 143,912
Total Liabilities 226,496 259,073
Redeemable noncontrolling interest [3] 21 28
Commitments and contingent liabilities (Note 12)
Equity attributable to Equitable Financial:    
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding 2 2
Additional paid-in capital 8,539 8,546
Accumulated deficit (206) (2,199)
Accumulated other comprehensive income (loss) (4,834) 2,357
Total Equity 3,501 8,706
Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 230,018 $ 267,807
[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.
[2] Represents the fair value of the ceded reserves to Venerable. See Note 1 of the Notes to these Consolidated Financial Statements for details of the Venerable Transaction and Note 7 of the Notes to these Consolidated Financial Statements.
[3] See Note 11 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.